WILMINGTON, Del., Feb. 25, 2025 /PRNewswire/ — Data360, Inc. has expanded the data available in its Identity Graph to allow deeper identity mapping, which is essential for healthcare marketers seeking to effectively identify, target, and engage audiences while satisfying compliance requirements.
Now enriched with digital identity (MAIDs, phone number, IP, etc.), Data360’s audience data is more valuable than ever before. Not only does Data360 offer the industry’s only 100% first-party, deterministic database to fuel programs designed for Physicians, HCPs, Nurses, Patients, Consumers, and B2B audiences, but it’s also the only database with IP mapped to NPI number, which is a significant competitive advantage for healthcare advertisers.
Advantages of Data360’s Identity Graph:
Coverage and quality of Data360’s Data Universe:
James J. Miller, President & CEO, Data360, Inc., says: “Data360 puts identity at the forefront of every solution, in order to offer our clients the ability to recruit and nurture audiences in ways no one else can – meeting every compliant requirement for identification, targeting, and communications.”
About Data360
Committed to turning data into intelligence, Data360, Inc. serves a mission to be the go-to trusted data partner leading the industry with Identity-First and Intent-Fueled Solutions for Healthcare Marketers. The company’s solutions and services allow marketers to gain broader and better access to physicians, HCPs, patients, and caregivers. Data360 delivers unequaled first-party data, proprietary technology extracting audience intent and behavior, and a focus on cost-effective and compliant ways to activate and engage healthcare audiences. Data360’s Fingerprint solution is proprietary technology that identifies intent and maps it to digital identity to enrich HCP and Patient profiles. Explore more at https://www.data360online.com/.
SOURCE Data360 Inc.
Milestone enables GMP manufacturing to accelerate clinical trials and transform global vaccine delivery BRISBANE, Australia…
BEIJING, Dec. 14, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading…
12 Month Timeline - How Cannabis Rescheduling Actually Takes EffectAnnouncementPresident signals intent or issues executive…
First FDA approved treatment in 30+ years for more than 2 million Americans with PSVT Novel…
NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- TrialWire®, the industry’s fastest, intelligent patient recruitment…
The skilled nursing, assisted and senior living provider reiterates dedication to a financial restructuring process…